Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Loss of Desmocollin 3 in skin tumor development and progression.

Chen J, O'Shea C, Fitzpatrick JE, Koster MI, Koch PJ.

Mol Carcinog. 2012 Jul;51(7):535-45. doi: 10.1002/mc.20818. Epub 2011 Jun 16.


Loss of desmocollin 3 in mice leads to epidermal blistering.

Chen J, Den Z, Koch PJ.

J Cell Sci. 2008 Sep 1;121(Pt 17):2844-9. doi: 10.1242/jcs.031518. Epub 2008 Aug 5.


Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells.

Nuber UA, Schäfer S, Stehr S, Rackwitz HR, Franke WW.

Eur J Cell Biol. 1996 Sep;71(1):1-13.


IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.

Rafei D, Müller R, Ishii N, Llamazares M, Hashimoto T, Hertl M, Eming R.

Am J Pathol. 2011 Feb;178(2):718-23. doi: 10.1016/j.ajpath.2010.10.016. Erratum in: Am J Pathol. 2013 Feb;182(2):610.


Epigenetic silencing of DSC3 is a common event in human breast cancer.

Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Muñoz-Rodríguez JL, Burr JA, Fitzgerald M, Pawar SC, Cress AE, Domann FE, Futscher BW.

Breast Cancer Res. 2005;7(5):R669-80. Epub 2005 Jun 16.


Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.

Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD.

PLoS Genet. 2010 Oct 21;6(10):e1001168. doi: 10.1371/journal.pgen.1001168.


The p53 target gene desmocollin 3 acts as a novel tumor suppressor through inhibiting EGFR/ERK pathway in human lung cancer.

Cui T, Chen Y, Yang L, Knösel T, Huber O, Pacyna-Gengelbach M, Petersen I.

Carcinogenesis. 2012 Dec;33(12):2326-33. doi: 10.1093/carcin/bgs273. Epub 2012 Aug 31.


A role for Rac1 activity in malignant progression of sebaceous skin tumors.

Frances D, Sharma N, Pofahl R, Maneck M, Behrendt K, Reuter K, Krieg T, Klein CA, Haase I, Niemann C.

Oncogene. 2015 Oct;34(43):5505-12. doi: 10.1038/onc.2014.471. Epub 2015 Feb 9.


Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.

Vitale-Cross L, Amornphimoltham P, Fisher G, Molinolo AA, Gutkind JS.

Cancer Res. 2004 Dec 15;64(24):8804-7.


Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.

Wang L, Liu T, Wang Y, Cao L, Nishioka M, Aguirre RL, Ishikawa A, Geng L, Okada N.

Virchows Arch. 2007 Nov;451(5):959-66. Epub 2007 Sep 11.


Genomic organization and amplification of the human desmosomal cadherin genes DSC1 and DSC3, encoding desmocollin types 1 and 3.

Whittock NV, Hunt DM, Rickman L, Malhi S, Vogazianou AP, Dawson LF, Eady RA, Buxton RS, McGrath JA.

Biochem Biophys Res Commun. 2000 Sep 24;276(2):454-60.


Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.

Kiguchi K, Bol D, Carbajal S, Beltrán L, Moats S, Chan K, Jorcano J, DiGiovanni J.

Oncogene. 2000 Aug 31;19(37):4243-54.


Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.

Bowden GT, Schneider B, Domann R, Kulesz-Martin M.

Cancer Res. 1994 Apr 1;54(7 Suppl):1882s-1885s. Review.


Desmocollin 3 is required for pre-implantation development of the mouse embryo.

Den Z, Cheng X, Merched-Sauvage M, Koch PJ.

J Cell Sci. 2006 Feb 1;119(Pt 3):482-9. Epub 2006 Jan 17.


Antisense expression of a desmocollin gene in MDCK cells alters desmosome plaque assembly but does not affect desmoglein expression.

Roberts GA, Burdett ID, Pidsley SC, King IA, Magee AI, Buxton RS.

Eur J Cell Biol. 1998 Jul;76(3):192-203.


Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.

Macias E, Kim Y, Miliani de Marval PL, Klein-Szanto A, Rodriguez-Puebla ML.

Cancer Res. 2007 Oct 15;67(20):9713-20.


Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation.

Chidgey M, Brakebusch C, Gustafsson E, Cruchley A, Hail C, Kirk S, Merritt A, North A, Tselepis C, Hewitt J, Byrne C, Fassler R, Garrod D.

J Cell Biol. 2001 Nov 26;155(5):821-32. Epub 2001 Nov 19.


Desmosomal defects in acantholytic squamous cell carcinomas.

O'Shea C, Fitzpatrick JE, Koch PJ.

J Cutan Pathol. 2014 Nov;41(11):873-9. doi: 10.1111/cup.12390. Epub 2014 Nov 4.


Expression of desmosomal proteins in acantholytic squamous cell carcinoma of the skin.

Jurčić V, Kukovič J, Zidar N.

Histol Histopathol. 2015 Aug;30(8):945-53. doi: 10.14670/HH-11-599. Epub 2015 Feb 27.


Supplemental Content

Support Center